View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Amicus Therapeutics Presents New Long-term Data for both Galafold® (mi...

Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026 PRINCETON, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), today announced the presentation of new data from clinical and real-world studies of Galafold® (migalastat) in Fabry disease and POMBILITI® + OPFOLDA® (cipaglucosidase alfa plus miglustat) in late-onset Pompe disease. Data are being presented at the . “Amicus continues to advance the science and understanding of both Fabry and Pompe disea...

 PRESS RELEASE

Carpenter Technology Reports Second Quarter Fiscal Year 2026 Results

Carpenter Technology Reports Second Quarter Fiscal Year 2026 Results Delivered Record Quarterly Operating IncomeExpanded Operating Margins in Specialty Alloys Operations SegmentExceeded Second Quarter Operating Income Guidance for Specialty Alloys Operations SegmentDemand Accelerating in Aerospace and Defense End-Use Market with Higher Sequential BookingsCompleted Negotiations for Several Aerospace Long-Term Agreements with Significant Value Realization Increased Operating Income Guidance for Fiscal Year 2026 PHILADELPHIA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporat...

 PRESS RELEASE

Carpenter Technology Declares Quarterly Cash Dividend

Carpenter Technology Declares Quarterly Cash Dividend PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable March 5, 2026, to shareholders of record on January 27, 2026. About Carpenter TechnologyCarpenter Technology Corporation is a recognized leader in high-performance specialty alloy materials and process solutions for critical applications in the aerospace and defense, medical, and other markets. Founded in 1889, Carpenter Tec...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakouts Just Keep Coming; Upgrading Materials We maintain our near-term bullish outlook on the S&P 500 (SPX), Nasdaq 100 (QQQ), and Russell 2000 (IWM), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we flipped to neutral. We will stay near-term bullish as long as crucial support levels of 6824 on SPX (up from 6480-6520), $610 on QQQ, and $245 on IWM continue to hold. Just last week (1/6/26 Compass) we discussed the many breakouts (most notably the Russ...

 PRESS RELEASE

Carpenter Technology Announces Conference Call and Webcast

Carpenter Technology Announces Conference Call and Webcast PHILADELPHIA, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, January 29, 2026 at 10:00 a.m. ET to discuss the results of operations for the second quarter of fiscal year 2026, ended December 31, 2025. The call and webcast will follow the release of second quarter fiscal 2026 financial results before the market opens on Thursday, January 29, 2026. Conference Call and Webcast Details What: Carpenter Technology Second Quarter Fiscal 2026 Confe...

Kingsway Financial Services Inc: 2 directors

Two Directors at Kingsway Financial Services Inc sold 49,229 shares at between 12.800USD and 13.324USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...

Carpenter Technology Corp: 1 director

A director at Carpenter Technology Corp sold 3,900 shares at 321.246USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

 PRESS RELEASE

Carpenter Technology Corporation Announces Closing of $700.0 Million P...

Carpenter Technology Corporation Announces Closing of $700.0 Million Private Offering of 5.625% Senior Notes Due 2034 and Amendment of Credit Agreement PHILADELPHIA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) announced today the closing of its previously announced offering of $700.0 million aggregate principal amount of 5.625% senior notes due 2034 (the “Notes”) through a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A and to certain persons outside of the United States pursuant ...

Carpenter Technology Corporation: Update to credit considerations

Our credit view of this issuer reflects its very strong liquidity position and strong technical capabilities, offset by its moderate scale versus higher rated entities.

 PRESS RELEASE

Carpenter Technology Corporation Announces Pricing of $700.0 Million P...

Carpenter Technology Corporation Announces Pricing of $700.0 Million Private Offering of 5.625% Senior Notes Due 2034 PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) announced today that it priced an offering of $700.0 million aggregate principal amount of 5.625% senior notes due 2034 (the “Notes”) at par through a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A and to certain persons outside of the United States pursuant to Regulation S, each under the Securities Act of...

Moody's Ratings assigns Ba2 rating to Carpenter Technology's proposed ...

Moody's Ratings (Moody's) assigned a Ba2 rating to Carpenter Technology Corporation's (Carpenter) proposed $700 million senior unsecured notes due 2034. The company plans to use the proceeds along with a portion of its cash balance to fund the repayment of its $400 million senior unsecured notes due...

 PRESS RELEASE

Carpenter Technology Corporation Announces Proposed $700.0 Million Pri...

Carpenter Technology Corporation Announces Proposed $700.0 Million Private Offering of Senior Notes Due 2034 PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced its intention to offer, subject to market and other conditions, $700.0 million aggregate principal amount of its senior notes due 2034 (the “Notes”) through a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A and to certain persons outside of the United States pursuant to Regulation S, each under the Se...

 PRESS RELEASE

Amicus Therapeutics Announces Third Quarter 2025 Financial Results an...

Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates Q3 2025 Total Revenue of $169M, up 17% at CER Positive Q3 2025 GAAP Net Income of $17M Cash Position of $264M, a $33M Increase in Q3 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the quarter ended September 30, 2025. “Amicus achieved yet another impressive qu...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: November 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Amicus Therapeutics to Present at Upcoming Investor Conferences in Nov...

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ETJefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT A live audio webcast of each presentation can also be accessed via the investors se...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: October 27, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Carpenter Technology Reports First Quarter Fiscal Year 2026 Results

Carpenter Technology Reports First Quarter Fiscal Year 2026 Results Delivered Record Quarterly Operating IncomeExpanded Operating Margins in Specialty Alloys Operations SegmentDemand Accelerating in Aerospace and Defense End-Use Market with Higher Sequential BookingsCompleted Negotiations for Several Aerospace Long-Term Agreements with Significant Value Realization PHILADELPHIA, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal first quarter ended September 30, 2025. For the quarter, the Company...

 PRESS RELEASE

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results o...

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss financial results for the quarter ended September 30, 2025. Participants and investors interested in accessing the call by phone will need to register using the . After registering, all phone participants will receive a dial-in number along with a personal PIN to access the eve...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch